Related references
Note: Only part of the references are listed.The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
A. Huijbers et al.
ANNALS OF ONCOLOGY (2013)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Susanne Sebens et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Twist1 Is Up-Regulated in Gastric Cancer-Associated Fibroblasts with Poor Clinical Outcomes
Chang Ohk Sung et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
Esther M. de Kruijf et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Ignacio Garrido-Laguna et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
Robin K. Kelley et al.
CLINICAL COLORECTAL CANCER (2011)
Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and Is a Good Prognostic Indicator of Colorectal Cancer
Da Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
Richard G. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Michael Allen et al.
JOURNAL OF PATHOLOGY (2011)
Mechanisms of Disease: Hypoxia and Inflammation.
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer
Anne Planche et al.
PLOS ONE (2011)
Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma
Vivekanand Gupta et al.
PLOS ONE (2011)
The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer
Ja Seung Koo et al.
TUMOR BIOLOGY (2011)
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
N. P. West et al.
BRITISH JOURNAL OF CANCER (2010)
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery
Sabine Tejpar et al.
ONCOLOGIST (2010)
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers
Amel Saadi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling
Russell D. Petty et al.
BMC CANCER (2009)
Clinical implications of microsatellite instability in sporadic colon cancers
Frank A. Sinicrope et al.
CURRENT OPINION IN ONCOLOGY (2009)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer et al.
NATURE MEDICINE (2009)
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer
Yuqiu Jiang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J. Cohen et al.
PANCREAS (2008)
Is adjuvant therapy for stage II colon cancer worthwhile, and for whom?
Neil H. Segal et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy
Nobuyuki Yanagisawa et al.
HUMAN PATHOLOGY (2007)
α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini
Julie C. Friedland et al.
JOURNAL OF CELL SCIENCE (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
Eva J. A. Morris et al.
GUT (2007)
Advances in and limitations of up-and-down methodology - A precis of clinical use, study design, and dose estimation in anesthesia research
Nathan L. Pace et al.
ANESTHESIOLOGY (2007)
PAV and the ROC convex hull
Tom Fawcett et al.
MACHINE LEARNING (2007)
Stromal myofibroblasts predict disease recurrence for colorectal cancer
Tadashi Tsujino et al.
CLINICAL CANCER RESEARCH (2007)
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
C. Y. Ngan et al.
BRITISH JOURNAL OF CANCER (2007)
Clinical implications of fibroblast activation protein in patients with colon cancer
Leonard R. Henry et al.
CLINICAL CANCER RESEARCH (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified
RL Ward et al.
JOURNAL OF PATHOLOGY (2005)
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Exploring the tumour environment:: cancer-associated fibroblasts as targets in cancer therapy
P Micke et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress
E Sivridis et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Histological categorisation of fibrotic cancer stroma in advanced rectal cancer
H Ueno et al.
GUT (2004)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumour-stroma interaction:: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
P Micke et al.
LUNG CANCER (2004)
Tumor-stroma interaction of human pancreatic cancer: Acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins
H Miyamoto et al.
PANCREAS (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Modelling the relationship between continuous covariates and clinical events using isotonic regression
M Ancukiewicz et al.
STATISTICS IN MEDICINE (2003)
Growth inhibitory signalling by TGFβ is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus
B Jiang et al.
CELLULAR SIGNALLING (2003)
Role of tissue stroma in cancer cell invasion
O De Wever et al.
JOURNAL OF PATHOLOGY (2003)
A nonparametric changepoint model for stratifying continuous variables under order restrictions and binary outcome
G Salanti et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2003)
Modified scar grade - A prognostic indicator in small peripheral lung adenocarcinoma
AM Maeshima et al.
CANCER (2002)
β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
VM Weaver et al.
CANCER CELL (2002)
Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer
VC Petersen et al.
GUT (2002)
Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in advanced rectal cancer
H Ueno et al.
HISTOPATHOLOGY (2002)
Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines
G Kouniavsky et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation
JS Damiano et al.
LEUKEMIA (2001)
Transforming growth factor-β1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells
K Fujimoto et al.
EXPERIMENTAL CELL RESEARCH (2001)
Ras-mediated suppression of TGFβRII expression in intestinal epithelial cells involves Raf-independent signaling
NM Bulus et al.
NEOPLASIA (2000)
Share Paper
